During the last decade, remarkable progress has been made in the area of photoacoustic imaging and its biomedical applications. This is due to the demand for safe, high-contrast, and high spatial resolution techniques for the early diagnosis and monitoring of disease. Photoacoustic imaging uses nonionizing waves, which pose no health hazard, compared with ionizing x-ray radiation. Moreover, photoacoustic imaging presents advantages over traditional pure optical and ultrasound imaging techniques. Several groups have developed photoacoustic imaging technologies in different forms.
1 Photoacoustic tomography (PAT) has shown potential to generate images with optical contrast and ultrasonic spatial resolution at significant tissue depths.
2, 3 Maslov
4 and Zhang
5 demonstrated dark-field photoacoustic microscopy (PAM), where high-contrast photoacoustic images were produced by raster-scanning a light delivery and acoustic detection probe mechanically. Advances in PAM and PAT technology include optical detection of photoacoustic signals,
6 and the use of ultrasound arrays to improve imaging speed,
7 among others. Due to optical contrast, photoacoustic imaging offers considerable opportunities for functional and molecular imaging, including imaging of blood oxygen saturation, imaging of gene expression, and imaging of contrast agents and optically absorbing nanoparticles.
8 In PAM and PAT, the lateral spatial resolution is determined by the ultrasonic focal width, while the axial spatial resolution is determined primarily by the transducer receiving bandwidth.